These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 10525402

  • 21. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
    Batra-Safferling R, Granzin J, Mödder S, Hoffmann S, Willbold D.
    Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
    [Abstract] [Full Text] [Related]

  • 22. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ, Leiting B, Pryor K, Mueller L, Farmer BT.
    Biochemistry; 1996 May 21; 35(20):6201-11. PubMed ID: 8639560
    [Abstract] [Full Text] [Related]

  • 23. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 2000 Jun 02; 299(2):521-35. PubMed ID: 10860756
    [Abstract] [Full Text] [Related]

  • 24. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ, King CR, Cao T, Kelley J, Milne GW, Voigt JH, Burke TR.
    J Med Chem; 1999 Jan 14; 42(1):25-35. PubMed ID: 9888830
    [Abstract] [Full Text] [Related]

  • 25. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN, Fulton DB, Andreotti AH.
    J Mol Biol; 2000 Sep 22; 302(3):607-23. PubMed ID: 10986122
    [Abstract] [Full Text] [Related]

  • 26. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS, Shewchuk LM, Rocque W, Hummel CW, Jordan SR, Mohr C, Pacofsky GJ, Peel MR, Rodriguez M, Sternbach DD, Consler TG.
    Biochemistry; 1997 May 27; 36(21):6283-93. PubMed ID: 9174343
    [Abstract] [Full Text] [Related]

  • 27. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM, Grucza RA, Ladbury JE, Waksman G.
    Biochemistry; 1998 Jun 23; 37(25):9083-90. PubMed ID: 9636054
    [Abstract] [Full Text] [Related]

  • 28. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D, Wieligmann K, Hampel K, Nothmann D, Zoda MS, Schmidt-Arras D, Zacharias M, Böhmer FD, Reissmann S.
    J Med Chem; 2005 Mar 10; 48(5):1528-39. PubMed ID: 15743195
    [Abstract] [Full Text] [Related]

  • 29. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
    Folmer RH, Geschwindner S, Xue Y.
    Biochemistry; 2002 Dec 03; 41(48):14176-84. PubMed ID: 12450381
    [Abstract] [Full Text] [Related]

  • 30. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.
    Llinaś-Brunet M, Beaulieu PL, Cameron DR, Ferland JM, Gauthier J, Ghiro E, Gillard J, Gorys V, Poirier M, Rancourt J, Wernic D, Betageri R, Cardozo M, Jakes S, Lukas S, Patel U, Proudfoot J, Moss N.
    J Med Chem; 1999 Feb 25; 42(4):722-9. PubMed ID: 10052978
    [Abstract] [Full Text] [Related]

  • 31. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.
    Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, Resh MD, Rios CB, Silverman L, Kuriyan J.
    Nature; 1992 Aug 20; 358(6388):646-53. PubMed ID: 1379696
    [Abstract] [Full Text] [Related]

  • 32. Correlation between dynamics and high affinity binding in an SH2 domain interaction.
    Kay LE, Muhandiram DR, Farrow NA, Aubin Y, Forman-Kay JD.
    Biochemistry; 1996 Jan 16; 35(2):361-8. PubMed ID: 8555205
    [Abstract] [Full Text] [Related]

  • 33. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT, Serrano L, Wilmanns M.
    J Mol Biol; 1998 Aug 21; 281(3):513-21. PubMed ID: 9698566
    [Abstract] [Full Text] [Related]

  • 34. Crystal structure of the phosphotyrosine recognition domain SH2 of the Src oncogene product complexed with tyrosine-phosphorylated peptides.
    Waksman G.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 21; 40(5):611-8. PubMed ID: 7526915
    [Abstract] [Full Text] [Related]

  • 35. Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain.
    Plummer MS, Lunney EA, Para KS, Prasad JV, Shahripour A, Singh J, Stankovic CJ, Humblet C, Fergus JH, Marks JS, Sawyer TK.
    Drug Des Discov; 1996 Apr 21; 13(3-4):75-81. PubMed ID: 8874045
    [Abstract] [Full Text] [Related]

  • 36. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
    Knoechel TR, Tucker AD, Robinson CM, Phillips C, Taylor W, Bungay PJ, Kasten SA, Roche TE, Brown DG.
    Biochemistry; 2006 Jan 17; 45(2):402-15. PubMed ID: 16401071
    [Abstract] [Full Text] [Related]

  • 37. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
    Huang N, Nagarsekar A, Xia G, Hayashi J, MacKerell AD.
    J Med Chem; 2004 Jul 01; 47(14):3502-11. PubMed ID: 15214778
    [Abstract] [Full Text] [Related]

  • 38. Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains.
    Karthikeyan S, Leung T, Birrane G, Webster G, Ladias JA.
    J Mol Biol; 2001 May 18; 308(5):963-73. PubMed ID: 11352585
    [Abstract] [Full Text] [Related]

  • 39. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
    Qiu X, Pohl E, Holmes RK, Hol WG.
    Biochemistry; 1996 Sep 24; 35(38):12292-302. PubMed ID: 8823163
    [Abstract] [Full Text] [Related]

  • 40. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
    Weber T, Schaffhausen B, Liu Y, Günther UL.
    Biochemistry; 2000 Dec 26; 39(51):15860-9. PubMed ID: 11123912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.